People | September 08, 2025
Zydus Lifesciences appoints Nitin Parekh as President (Special Projects)
He has been associated with the Zydus Group since 2009
He has been associated with the Zydus Group since 2009
The medicine was well tolerated, with no unexpected safety issue
Free cash flow also reached €63 million, representing an 11 percent increase compared to the high benchmark set in 2024
Enlicitide achieved all primary and key secondary endpoints, demonstrating statistically significant and clinically meaningful reductions in low-density lipoprotein cholesterol
He will be leading the design and execution of transformative strategies that harness the power of AI and automation, drive process optimization, and ignite digital innovation
The trial is the largest to date evaluating Leqvio and the first to focus on patient-centered outcomes
The hospital opens with 300 operational beds, including 100+ ICU beds and 5 advanced operating theatres
First Indian company to follow global recommendations in accordance with the World Health Organisation (WHO)
The positive benefit-risk profile of vericiguat in its approved indication in patients with HFrEF following a recent heart failure event based on the pivotal Phase III VICTORIA trial remains unchanged
The study showed a significant 29% reduction in the risk for heart attack, stroke and death from any cause in the Wegovy users
Subscribe To Our Newsletter & Stay Updated
